ClinicalTrials.Veeva

Menu

Interest of the Tool: Evaluation of Specific Care in an Ecological Environment for Patients Suffering From Schizophrenia-like Disorders (IEvaEcoSchi)

C

Centre Hospitalier Henri Laborit

Status

Enrolling

Conditions

Patients With Schizophrenia-like Disorders

Treatments

Other: ESSME questionnaire

Study type

Interventional

Funder types

Other

Identifiers

NCT05349513
2022-A00080-43

Details and patient eligibility

About

The study use a new ecological questionnaire called ESSME developed by a care team in order to evaluate ecological environment of patients with schizophrenia-like disorders.

Indeed, evaluation in an ecological environment would make it possible to be as close as possible to the concerns of theses patients, which could improve the care of this population, by making it possible to set with the patient objectives anchored in their daily life.

Full description

The duration of patient's participation to the study is 6 months plus 7 to 14 days.

The study includes the following visits :

  • V0: Inclusion visit (Day 0) with the administration of standard of care questionnaires;
  • V1: visit at patient's home (Day 0 +7 to 14 days) with the administration of the experimental ESSME questionnaire;
  • V2: follow-up visit at 6 months (M6) with the administration of the same standard of care questionnaires than at the inclusion visit;
  • V3: visit at patient's home (M6 + 7 to 14 days) with the administration of the experimental ESSME questionnaire.

Enrollment

56 estimated patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • man or woman aged 18 to 65 inclusive;
  • diagnosis of schizophrenia or schizoaffective disorder according to the Diagnostic and Statistical Manual of Mental Disorders version number 5 (DSM-V) criteria;
  • patient receiving care in a Center for Rehabilitation and Intersectoral Therapeutic Activities (CREATIV);
  • person who consented to the study;
  • affiliate or beneficiary of a social security scheme.

Exclusion criteria

  • patient aged under 18 or over 65;
  • pregnant or breastfeeding women;
  • person unable or unwilling to receive a home visit;
  • person not consenting to the study;
  • presence of a diagnosis of an associated neurodevelopmental disorder;
  • presence of a diagnosis of dementia or associated neurodegenerative process;
  • person with a level of French language insufficient to understand the items.

Trial design

Primary purpose

Other

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

56 participants in 1 patient group

interventionnal arm
Experimental group
Description:
Administration of the experimental questionnaire ESSME in patient's environment.
Treatment:
Other: ESSME questionnaire

Trial contacts and locations

1

Loading...

Central trial contact

Carole WANGERMEZ

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems